Evolent Health, Inc. (EVH) Analysts See $-0.10 EPS as of May, 8

April 16, 2018 - By Benjamin Allen

Evolent Health, Inc. (NYSE:EVH) Corporate Logo

Evolent Health, Inc. (NYSE:EVH) is anticipated to reveal earnings on May, 8., according to Faxor. This year’s earnings per share analyst estimate is anticipated to be $-0.10. That is 61.54 % up compareed to $-0.26 earnings per share for last year. 0.00 % EPS growth is what analysts predict. $-0.10 earnings per share was published for last [previous quarter]. On during the last trading session the stock increased $0.1 or 0.64%, reaching $15.8.Evolent Health, Inc. has volume of 405,938 shares. Since April 17, 2017 EVH has declined 34.82% and is downtrending. EVH underperformed the S&P500 by 46.37%.

Evolent Health, Inc. (NYSE:EVH) Ratings Coverage

Total analysts of 8 have positions in Evolent Health (NYSE:EVH) as follows: 8 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since October 31, 2017 according to StockzIntelligence Inc Evolent Health has 12 analyst reports. In Thursday, January 11 report Robert W. Baird maintained the stock with “Buy” rating. On Wednesday, January 10 the firm has “Buy” rating by KeyBanc Capital Markets given. On Tuesday, October 31 the rating was maintained by Robert W. Baird with “Buy”. On Tuesday, February 13 Jefferies maintained Evolent Health, Inc. (NYSE:EVH) rating. Jefferies has “Buy” rating and $22.0 target. On Tuesday, January 2 Cantor Fitzgerald maintained Evolent Health, Inc. (NYSE:EVH) with “Buy” rating. On Friday, November 10 the firm has “Buy” rating by Cantor Fitzgerald given. On Thursday, November 16 the stock of Evolent Health, Inc. (NYSE:EVH) earned “Buy” rating by Leerink Swann. On Wednesday, February 28 Canaccord Genuity maintained Evolent Health, Inc. (NYSE:EVH) with “Buy” rating. The company rating was maintained by Canaccord Genuity on Monday, December 11. On Wednesday, February 28 Wells Fargo maintained Evolent Health, Inc. (NYSE:EVH) rating. Wells Fargo has “Outperform” rating and $20 target.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States.The firm is valued at $1.22 billion. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management.Last it reported negative earnings. The company's services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.

Evolent Health, Inc. (NYSE:EVH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.